Touma et al reported an activity index for systemic lupus erythematosus (SLE) based on the SLEDAI-2K and the daily glucocorticoid dose. The authors are from the University of Toronto.
Patient selection: SLE treated only with corticosteroids
Parameters:
(1) SLEDAI-2K, from 0 to 105
(2) glucocorticoid (GC) dose in mg per day (presumably prednisone-equivalent)